Detalhe da pesquisa
1.
Analysis of 10 Adrenocortical Carcinoma Patients in the Cohort of the Precision Medicine Platform MONDTI.
Oncology;
94(5): 306-310, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29444511
2.
Feasibility of personalized treatment concepts in gastrointestinal malignancies: Sub-group results of prospective clinical phase II trial EXACT.
Chin J Cancer Res;
30(5): 508-515, 2018 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30510362
3.
Effects of cilengitide in osteoclast maturation and behavior.
Exp Cell Res;
337(1): 68-75, 2015 Sep 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26209605
4.
Integrins in the Spotlight of Cancer.
Int J Mol Sci;
17(12)2016 Dec 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27929432
5.
Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior.
J Cancer;
13(7): 2271-2280, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35517419
6.
Bead-Based Isolation of Circulating Tumor DNA from Pancreatic Cancer Patients Enables High Fidelity Next Generation Sequencing.
Cancer Manag Res;
13: 6249-6261, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34393517
7.
Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients.
J Clin Med;
9(3)2020 Feb 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32121198
8.
Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC.
Ther Adv Med Oncol;
12: 1758835920928635, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32922518
9.
Different Toxicity Profiles Predict Third Line Treatment Efficacy in Metastatic Colorectal Cancer Patients.
J Clin Med;
9(6)2020 Jun 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32517383
10.
A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid.
Ther Adv Med Oncol;
11: 1758835919853196, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31360237
11.
SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment.
Transl Oncol;
12(1): 15-23, 2019 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30245304
12.
Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI.
ESMO Open;
4(4): e000538, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31423337
13.
Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology.
Oncotarget;
10(9): 942-952, 2019 Jan 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30847023
14.
Challenges and Perspectives for Immunotherapy in Adenocarcinoma of the Pancreas: The Cancer Immunity Cycle.
Pancreas;
47(2): 142-157, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29346215
15.
Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy.
Med Oncol;
36(1): 1, 2018 Nov 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30426271
16.
Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and Regorafenib.
Clin Colorectal Cancer;
17(4): 274-279, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30042010
17.
Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer.
Memo;
10(3): 136-140, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28989542
18.
Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel.
Sci Rep;
7(1): 4851, 2017 07 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28687745
19.
Nab-paclitaxel as alternative treatment regimen in advanced cholangiocellular carcinoma.
J Gastrointest Oncol;
7(4): 588-94, 2016 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27563449
20.
Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patients.
Thromb Res;
136(5): 865-9, 2015 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26440977